FI
PGNX

Fosun International’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Fosun International’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-472,580
Closed -$2.75M – 325
2019
Q2 		$2.75M Hold
472,580
– – 0.18% 85
2019
Q1 		$2.17M Buy
472,580
+17,992
+4% +$81.4K 0.14% 94
2018
Q4 		$1.77M Buy
454,588
+56,000
+14% +$285K 0.11% 95
2018
Q3 		$2.46M Buy
+398,588
New +$3.06M 0.12% 76

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fosun International's PGNX Position: Q3 2019 in Review

Fosun International sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2019, closing a stake of 472,580 shares — an estimated $2.75M sold.

Fosun International first reported a position in PGNX in Q3 2018 and held it in 4 quarters. The position peaked at $2.75M in Q2 2019. 135 funds tracked by Wall St. Rank hold PGNX as of Q3 2019.

  • Fosun International reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 472,580 Progenics Pharmaceuticals Inc shares in Q3 2019, an estimated $2.75M.
  • Fosun International first reported a position in Progenics Pharmaceuticals Inc in Q3 2018 and held it in 4 quarters.
  • Fosun International's Progenics Pharmaceuticals Inc position peaked at $2.75M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.